Correction to: Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies

Podobne zapisy

• Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies
  od: Bangs, Mark E., i wsp.
  Wydane: (2020)
• A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine
  od: Camporeale, Angelo, i wsp.
  Wydane: (2018)
• Evaluation of injection-site-related adverse events with galcanezumab: a post hoc analysis of phase 3 studies in participants with migraine
  od: Stauffer, Virginia L., i wsp.
  Wydane: (2020)
• Correction to: Functional impairment and disability among patients with migraine: evaluation of galcanezumab in a long-term, open-label study
  od: Ford, Janet H., i wsp.
  Wydane: (2020)
• Galcanezumab for migraine
  Wydane: (2020)